Evidence map›Paper›PMID 22205501›Full record

ArticleCell biochemistry and biophysics2013

Dysregulation of PTEN in cardiopulmonary vascular remodeling induced by pulmonary hypertension.

Yazhini Ravi, Karuppaiyah Selvendiran, Sarath Meduru, Lucas Citro, Shan Naidu, Mahmood Khan, Brian K Rivera, Chittoor B Sai-Sudhakar, Periannan Kuppusamy

Abstract read
In one paragraph

Article in Cell biochemistry and biophysics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Protective Effects of Curcumin on Pulmonary Arterial Hypertension.Advances in experimental medicine and biology · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yazhini RaviDepartment of Internal Medicine, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, 43210, USA.
Karuppaiyah Selvendiran
Sarath Meduru
Lucas Citro
Shan Naidu
Mahmood Khan
Brian K Rivera
Chittoor B Sai-Sudhakar
Periannan Kuppusamy
The Ohio State University · USLung Institute · US

Funding

PTENuating Restenosis: An Innovative PTEN Promoter for CardioprotectionR21HL095066 · NHLBI · OHIO STATE UNIVERSITY · PI KUPPUSAMY, PERIANNAN · 2009 to 2010
$413k
NHLBI NIH HHS HL095066NHLBI NIH HHS R21 HL095066
6 · The paper itself

Abstract

Pulmonary hypertension (PH) is a disorder of lung vasculature characterized by arterial narrowing. Phosphatase-and-tensin homolog on chromosome 10 (PTEN), associated in the progression of multiple cancers, is implicated in arterial remodeling. However, the involvement of PTEN in PH remains unclear. The objective of the present study was to determine the role of PTEN in pulmonary vascular remodeling using established models of PH. The study used rat models of PH, induced by monocrotaline (MCT) administration (60 mg/kg) or continuous hypoxic exposure (10% oxygen) for 3 weeks. Pulmonary artery smooth muscle cells (SMCs) were used for in vitro confirmation. Development of PH was verified by hemodynamic, morphological and histopathology analyses. PTEN and key downstream proteins in pulmonary and cardiac tissues were analyzed by western blotting and RT-PCR. PTEN was significantly decreased (MCT, 53%; Hypoxia, 40%), pAkt was significantly increased (MCT, 42%; Hypoxia, 55%) in tissues of rats with PH. Similar results were observed in SMCs exposed to hypoxia (1% oxygen) for 48 h. Ubiquitination assay showed that PTEN degradation occurs via proteasomal degradation pathway. Western blotting demonstrated a significant downregulation of cell-cycle regulatory proteins p53 and p27, and upregulation of cyclin-D1 in the lungs of both models. The results showed that PTEN-mediated modulation of PI3K pathway was independent of the focal adhesion kinase and fatty acid synthase. The study, for the first time, established that PTEN plays a key role in the progression of pulmonary hypertension. The findings may have potential for the treatment of pulmonary hypertension using PTEN as a target.

Indexed as

AnimalsCell Cycle ProteinsCell ProliferationGene Expression RegulationHeartHumansHypertension, PulmonaryHypoxiaLungMonocrotalineMyocardiumMyocytes, Smooth MuscleProteasome Endopeptidase ComplexProteolysisPTEN PhosphohydrolaseRatsCell Cycle ProteinsMonocrotalineProteasome Endopeptidase ComplexPTEN Phosphohydrolase

Identifiers

PMID22205501
PMCPMC4596526
OpenAlexW2045612798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.